Why are small, dense LDL particles considered more dangerous?

Small, dense LDL particles have a greater tendency to stick to artery walls, become oxidized more easily, and are less efficiently removed by LDL receptors, leading to greater accumulation and plaque formation.

Is low HDL cholesterol a direct cause of heart disease?

Low HDL cholesterol is strongly associated with increased heart disease risk, but it may be more of a marker for atherogenic dyslipidemia (including small LDL particles) rather than a direct cause. Efforts to raise HDL have not consistently reduced heart disease risk.

What role does inflammation play in heart disease and lipoprotein metabolism?

Inflammation is a key feature of atherosclerosis, converting benign cholesterol deposits into dangerous plaques. It also influences lipoprotein metabolism, potentially stimulating VLDL production as part of a host defense mechanism.

Does dietary cholesterol significantly impact blood cholesterol levels?

The effect of dietary cholesterol on blood cholesterol is generally small and often unmeasurable for most individuals. The body regulates cholesterol absorption, and its own production is a larger factor.

Are low-fat diets always beneficial for heart health?

Not necessarily. Studies show that low-fat diets, especially when high in carbohydrates, can paradoxically lead to smaller, denser LDL particles, promoting atherogenic dyslipidemia.

What are the main dietary culprits for promoting atherogenic dyslipidemia?

Simple sugars, particularly fructose, are considered potent drivers of atherogenic dyslipidemia on low-fat, high-carbohydrate diets. Processed foods and added sugars are generally problematic.

How effective are statins in lowering heart disease risk?

Statins are highly effective in lowering LDL cholesterol and reducing heart disease risk by 30-40% in many individuals. However, they may be less effective on smaller LDL particles and carry risks like developing type 2 diabetes.

Can statins cause type 2 diabetes?

Yes, a significant percentage of statin users, particularly women, have an increased risk of developing type 2 diabetes, which itself increases heart disease risk.

Why aren't LDL particle measurements more widely used in routine medical practice?

Confusion among physicians, methodological variations across different tests, and cost have historically limited the widespread adoption of LDL particle testing, though newer, standardized methods are improving accessibility and cost-effectiveness.

When should an LDL particle test be considered?

LDL particle testing is most valuable for individuals with borderline LDL cholesterol levels or when standard lipid panels don't fully explain risk, helping to refine risk assessment and guide treatment decisions.

What is absolute risk versus relative risk in heart disease?

Absolute risk is the actual probability of experiencing a heart event, while relative risk is the increase or decrease in that probability compared to a reference group. A high relative risk on a very low absolute risk still results in a small overall risk.

Dr. Ronald Krauss on LDL Cholesterol, Particle Size, Heart Disease & Atherogenic Dyslipidemia

FoundMyFitness

Education4 min read82 min video

Oct 16, 2015|270,425 views|4,280|558

very low-density lipoprotein LDL cholesterol HDL cholesterol Statin (Drug Class)atherogenic dyslipidemia Dr. Ronald M Krauss Ion Mobility cholesterol test Inflammation (Symptom)Lipopolysaccharide (Chemical Compound)Coronary Artery Disease (Disease Or Medical Condition)Cardiovascular Disease (Disease Or Medical Condition)

Save to Pod

Key Moments

TL;DR

Dr. Ronald Krauss explains LDL cholesterol, particle size, and atherogenic dyslipidemia, emphasizing small dense LDL as a key risk factor.

Key Insights

LDL cholesterol levels are a summation of various LDL particle sizes, not a complete picture of heart disease risk.

Smaller, denser LDL particles are more atherogenic (damaging to arteries) than larger, buoyant LDL particles, even if they carry less cholesterol.

Atherogenic dyslipidemia is a cluster of interrelated traits (small LDL, low HDL, high triglycerides) strongly linked to heart disease risk.

Dietary saturated fat's effect on heart disease risk is complex and may be less significant than previously thought, with the food context being crucial.

High carbohydrate intake, especially refined sugars and fructose, can promote the production of small, dense LDL particles.

Statins are effective in lowering LDL cholesterol and reducing heart disease risk, but their effects on smaller LDL particles are blunted, and they carry risks like increased incidence of type 2 diabetes.

THE COMPLEXITY OF CHOLESTEROL AND LIPROTEINS

For decades, cholesterol was oversimplified into 'good' HDL and 'bad' LDL. Dr. Ronald Krauss pioneered research showing that LDL cholesterol is not a single entity but a spectrum of particles varying in size and density. This groundbreaking work revealed that the size and concentration of these LDL particles, rather than just the total cholesterol measurement, are critical for understanding heart disease risk. Different forms of LDL have distinct metabolic and pathological properties, leading to a re-evaluation of how cholesterol contributes to atherosclerosis.

SMALL DENSE LDL: A SIGNIFICANT RISK FACTOR

The key insight is that smaller, denser LDL particles are more atherogenic. Despite carrying less cholesterol, these particles have a greater tendency to enter the artery wall, bind tightly, and become oxidized more rapidly. This process contributes significantly to plaque formation. Conversely, larger, more buoyant LDL particles, even if carrying more cholesterol, possess fewer pathological features. This distinction is crucial because standard LDL cholesterol measurements aggregate both types, potentially masking the true risk posed by a higher proportion of small, dense LDL.

ATHEROGENIC DYSLIPIDEMIA: A METABOLIC PROFILE

Dr. Krauss describes 'atherogenic dyslipidemia' as a cluster of interrelated traits strongly associated with heart disease. These include elevated levels of small, dense LDL particles, low levels of HDL cholesterol, and increased triglycerides and their remnants. This metabolic profile is considered the most important lipid-related trait linked to heart disease in the population. It highlights that the interplay between different lipoproteins is more critical than focusing on a single lipid marker, such as total LDL cholesterol.

DIETARY FACTORS AND THEIR IMPACT ON LIPID METABOLISM

The role of diet is complex. While earlier beliefs focused heavily on dietary cholesterol, research shows the body regulates cholesterol absorption, and dietary cholesterol has a minimal effect on blood cholesterol for most people. The context of food matters significantly. High carbohydrate intake, particularly simple sugars like fructose, is now understood to promote the production of VLDL, which in turn leads to smaller, denser LDL particles. Saturated fats' impact is also debated; they tend to increase larger LDL particles, which may be less harmful than small LDL.

INFLAMMATION AND THE EVOLUTION OF LIPROTEIN METABOLISM

Inflammation plays a significant role in heart disease, turning benign cholesterol deposits into dangerous plaques. Interestingly, lipoproteins like VLDL may have evolved to play a role in host defense, carrying pro-inflammatory and pro-thrombotic proteins to combat infections. In the presence of inflammatory signals (cytokines), the liver increases VLDL secretion. While this response is historically beneficial, in modern contexts, especially with the presence of endotoxins binding to lipoproteins, it can contribute to chronic inflammation and atherosclerosis.

STATINS AND THE MANAGEMENT OF CARDIOVASCULAR RISK

Statins are highly effective in lowering LDL cholesterol and reducing heart disease risk by increasing LDL receptor activity. However, they primarily target larger, cholesterol-rich LDL particles and have a blunted effect on smaller, denser LDL particles, which are particularly atherogenic. Furthermore, statin use is associated with potential adverse effects, including an increased risk of developing type 2 diabetes, especially in women. Precision medicine approaches, including advanced lipoprotein particle measurements, are needed to better identify individuals who will benefit most from statin therapy and to mitigate risks.

THE ROLE OF PARTICLE MEASUREMENTS IN CLINICAL PRACTICE

While standard lipid panels measuring total LDL cholesterol are useful, they do not fully capture an individual's cardiovascular risk. Advanced tests, such as those measuring LDL particle number and size (like those developed at CHORI using techniques like ion mobility), offer a more refined assessment, particularly for individuals with borderline LDL cholesterol levels. These tests can help physicians make more informed treatment decisions, guiding the use of statins or lifestyle interventions more effectively by identifying those most likely to benefit.

Mentioned in This Episode

●Supplements

●Software & Apps

●Tools

●Companies

●Organizations

●Concepts

●People Referenced

Common Questions

LDL cholesterol measures the amount of cholesterol within all LDL particles, while LDL particle measurement differentiates between sizes. Smaller, denser LDL particles are more strongly associated with heart disease risk.

Topics

Lipoprotein Particles Atherogenic Dyslipidemia Diet And Heart Health

Mentioned in this video

companyQuest Diagnostics

A company that partners with Dr. Krauss's research to offer advanced lipoprotein analysis methods.

conceptBuoyant LDL

Larger, more buoyant LDL particles associated with lower heart disease risk.

conceptLPS

Lipopolysaccharide, a component of bacterial cell walls that can bind to lipoproteins and may play a role in inflammation and atherosclerosis.

organizationChildren's Hospital Oakland Research Institute

Institution where Dr. Ronald Krauss directs the Atherosclerosis Research Center.

conceptDense LDL

Smaller, more dense LDL particles associated with higher heart disease risk due to their tendency to accumulate in artery walls.

conceptAtherogenic Dyslipidemia

A cluster of interrelated traits including small LDL, low HDL, and high triglycerides, significantly increasing heart disease risk.

conceptVLDL

Very low-density lipoprotein, triglyceride-rich particles produced by the liver that give rise to different forms of LDL.

conceptApolipoprotein B

The main protein forming the backbone of VLDL and LDL particles, crucial for their integrity and solubility in blood.

conceptSaturated Fatty Acids

A type of fat that can raise LDL levels; evidence suggests it primarily increases larger, less dangerous LDL particles in most people.

conceptProcessed Red Meat

Red meat, especially processed forms, which contain saturated fat and may have adverse effects on heart disease and longevity.

conceptRefined Carbohydrates

Carbohydrates that are processed and may have adverse effects on lipoprotein metabolism, particularly Simple sugars and fructose.

conceptSimple Sugars

Carbohydrates like fructose and glucose that are easily metabolized and likely culprits in promoting atherogenic dyslipidemia.

conceptFruits

Natural sources of fructose, but generally considered less problematic than added sugars due to fiber content and lower dosage.

conceptGlycemic Index

A measure of how quickly a carbohydrate-containing food raises blood glucose levels; its direct impact on lipoprotein metabolism and heart disease risk is debated.

softwareCore.org

Website associated with Dr. Krauss where information about him and his work can potentially be found.

toolIon Mobility

A physics-based technique used in advanced lipoprotein analysis to measure particle size and concentration.

personMark Shagaga

Mentioned as a person whose work directed the host to literature on inflammation and VLDL production.

supplementLDL

toolHDL